Genmab A-S (GMAB) had the highest return between May 1, 2012 and February 28, 2015 by a large-cap US stock, returning 1,031.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 5/1/2012 - 2/28/2015 | 1,031.8% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2012 - 2/28/2015 | 795.33% |
Insmed (INSM) | 5/1/2012 - 2/28/2015 | 541.52% |
DexCom (DXCM) | 5/1/2012 - 2/28/2015 | 521.06% |
Tesla (TSLA) | 5/1/2012 - 2/28/2015 | 513.75% |
Netflix (NFLX) | 5/1/2012 - 2/28/2015 | 491.5% |
Southwest Airlines (LUV) | 5/1/2012 - 2/28/2015 | 434.37% |
Constellation Brands Inc Class A (STZ) | 5/1/2012 - 2/28/2015 | 431.36% |
Neurocrine Biosciences (NBIX) | 5/1/2012 - 2/28/2015 | 426.28% |
Booz Allen Hamilton (BAH) | 5/1/2012 - 2/28/2015 | 417.68% |
Axon Enterprise (AXON) | 5/1/2012 - 2/28/2015 | 409.33% |
Micron Technology (MU) | 5/1/2012 - 2/28/2015 | 366.81% |
Pilgrims Pride (PPC) | 5/1/2012 - 2/28/2015 | 354.48% |
Cheniere Energy (LNG) | 5/1/2012 - 2/28/2015 | 342.54% |
Mr Cooper (COOP) | 5/1/2012 - 2/28/2015 | 339.66% |
Illumina (ILMN) | 5/1/2012 - 2/28/2015 | 338.74% |
Celsius (CELH) | 5/1/2012 - 2/28/2015 | 318.56% |
Delta Air Lines (DAL) | 5/1/2012 - 2/28/2015 | 305.79% |
Diamondback Energy (FANG) | 5/1/2012 - 2/28/2015 | 299.61% |
Gilead Sciences (GILD) | 5/1/2012 - 2/28/2015 | 298.58% |
Manhattan Associates (MANH) | 5/1/2012 - 2/28/2015 | 297.77% |
Broadcom (AVGO) | 5/1/2012 - 2/28/2015 | 289.02% |
Corpay (CPAY) | 5/1/2012 - 2/28/2015 | 286.38% |
AerCap (AER) | 5/1/2012 - 2/28/2015 | 285.62% |
Incyte (INCY) | 5/1/2012 - 2/28/2015 | 278.19% |
Large-cap stocks are treated as having a market cap of $10B+.
